Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 319

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients

Open access
Colmenero, Jordi, Rodríguez-Perálvarez, Manuel, Salcedo, Magdalena, Arias-Milla, Ana, Muñoz-Serrano, Alejandro, Graus, Javier, Nuño, Javier, Gastaca, Mikel, Bustamante-Schneider, Javier, Cachero, Alba, Lladó, Laura, Caballero, Aránzazu, Fernández-Yunquera, Ainhoa, Loinaz, Carmelo, Fernández, Inmaculada, Fondevila, Constantino, Navasa, Miquel, Iñarrairaegui, Mercedes, Castells, Lluis, Pascual, Sonia, Ramírez, Pablo, Vinaixa, Carmen, González-Dieguez, María Luisa, González-Grande, Rocío, Hierro, Loreto, Nogueras, Flor, Otero, Alejandra, Álamo, José María, Blanco-Fernández, Gerardo, Fábrega, Emilio, García-Pajares, Fernando, Montero, José Luis, Tomé, Santiago, De la Rosa, Gloria, Pons, José Antonio·2021·Journal of Hepatology

Abstract

Background & Aims The incidence and outcomes of coronavirus disease 2019 (COVID-19) in immunocompromised patients are a matter of debate. Methods We performed a prospective nationwide study including a consecutive cohort of liver transplant patients with COVID-19 recruited during the Spanish outbreak from 28 February to 7 April, 2020. The primary outcome was severe COVID-19, defined as the need for mechanical ventilation, intensive care, and/or death. Age- and gender-standardised incidence and mortality ratios (SIR and SMR) were calculated using data from the Ministry of Health and the Spanish liver transplant registry. Independent predictors of severe COVID-19 among hospitalised patients were analysed using multivariate Cox regression. Results A total of 111 liver transplant patients were diagnosed with COVID-19 (SIR = 191.2 [95% CI 190.3–192.2]). The epidemiological curve and geographic distribution overlapped widely between the liver transplant and general populations. After a median follow-up of 23 days, 96 patients (86.5%) were admitted to hospital and 22 patients (19.8%) required respiratory support. A total of 12 patients were admitted to the ICU (10.8%). The mortality rate was 18%, which was lower than in the matched general population (SMR = 95.5 [95% CI 94.2–96.8]). Overall, 35 patients (31.5%) met criteria of severe COVID-19. Baseline immunosuppression containing mycophenolate was an independent predictor of severe COVID-19 (relative risk = 3.94; 95% CI 1.59–9.74; p = 0.003), particularly at doses higher than 1,000 mg/day (p = 0.003). This deleterious effect was not observed with calcineurin inhibitors or everolimus and complete immunosuppression withdrawal showed no benefit. Conclusions Being chronically immunosuppressed, liver transplant patients have an increased risk of acquiring COVID-19 but their mortality rates are lower than the matched general population. Upon hospital admission, mycophenolate dose reduction or withdrawal could help in preventing severe COVID-19. However, complete immunosuppression withdrawal should be discouraged. Lay summary In liver transplant patients, chronic immunosuppression increases the risk of acquiring COVID-19 but it could reduce disease severity. Complete immunosuppression withdrawal may not be justified. However, mycophenolate withdrawal or temporary conversion to calcineurin inhibitors or everolimus until disease resolution could be beneficial in hospitalised patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jhep.2020.07.040

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 22 references

Cited by

See all 319

Metadata

Authors
Colmenero, J., Rodríguez-Perálvarez, M., Salcedo, M., Arias-Milla, A., Muñoz-Serrano, A., Graus, J., Nuño, J., Gastaca, M., Bustamante-Schneider, J., Cachero, A., Lladó, L., Caballero, A., Fernández-Yunquera, A., Loinaz, C., Fernández, I., Fondevila, C., Navasa, M., Iñarrairaegui, M., Castells, L., Pascual, S., Ramírez, P., Vinaixa, C., González-Dieguez, M. L., González-Grande, R., Hierro, L., Nogueras, F., Otero, A., Álamo, J. M., Blanco-Fernández, G., Fábrega, E., García-Pajares, F., Montero, J. L., Tomé, S., De la Rosa, G., & Pons, J. A.
Venue
Journal of Hepatology
Publisher
Elsevier BV
Published
2021-01
Volume
74
Issue
1
Pages
148-155
ISSN
0168-8278 (ISSN-L)
OpenAlex
W3046501796
Cited by
319
References
22
FWCI
8.27
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients. https://app.cochat.ai/papers/10.1016/j.jhep.2020.07.040
The paper
Colmenero, J., Rodríguez-Perálvarez, M., Salcedo, M., Arias-Milla, A., Muñoz-Serrano, A., Graus, J., Nuño, J., Gastaca, M., Bustamante-Schneider, J., Cachero, A., Lladó, L., Caballero, A., Fernández-Yunquera, A., Loinaz, C., Fernández, I., Fondevila, C., Navasa, M., Iñarrairaegui, M., Castells, L., . . . Pons, J. A. (2021). Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients. Journal of Hepatology. https://doi.org/10.1016/j.jhep.2020.07.040

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.